TABLE 1

Effect of various compounds on the uptakes of DAPI and [3H]cimetidine mediated by hMATEs stably expressed in MDCKII cells

The uptakes of DAPI (0.5 μM) and [3H]cimetidine (50 nM) were evaluated at 37°C and pH 7.4 for 10 min (DAPI) or 20 s ([3H]cimetidine) in MDCKII cells stably expressing hMATE1, those expressing hMATE2-K, and mock cells in the presence or absence of a test compound. The specific uptakes by hMATEs are presented as means ± S.E. (n = 8). The control values for DAPI uptake were 2.34 and 3.70 FI/mg protein, respectively, for hMATE1 and hMATE2-K, and for cimetidine uptake were 0.75 and 0.39 pmol/mg protein, respectively.

CompoundConc.Uptake
hMATE1hMATE2-K
DAPI[3H]CimetidineDAPI[3H]Cimetidine
mM%control
None (control)100.0 ± 1.4100.0 ± 3.0100.0 ± 1.5100.0 ± 1.5
Cimetidine0.2N.D.N.D.24.6 ± 1.6*3.1 ± 0.7*
Clonidine0.245.4 ± 1.3*18.4 ± 0.5*65.2 ± 3.3*24.2 ± 1.2*
Corticosterone0.234.0 ± 2.0*27.6 ± 0.4*49.8 ± 2.6*13.5 ± 0.5*
Diphenhydramine0.234.1 ± 1.5*23.6 ± 0.9*57.2 ± 2.1*41.4 ± 1.7*
Diltiazem0.2N.D.5.8 ± 0.2*47.4 ± 2.1*33.6 ± 2.2*
Estrone-3-sulfate0.280.5 ± 2.4*65.9 ± 0.6*100.8 ± 4.670.0 ± 2.8*
Guanidine292.3 ± 2.692.9 ± 2.8103.8 ± 1.887.8 ± 0.8*
Imipramine0.21.0 ± 0.6*11.5 ± 0.3*19.2 ± 1.4*25.9 ± 0.6*
MPP0.260.6 ± 1.7*27.7 ± 0.4*82.8 ± 3.6*27.3 ± 1.8*
Nicotinamide0.2105.1 ± 2.8106.6 ± 5.1112.0 ± 2.8*97.0 ± 1.7
NMN2111.1 ± 1.8*123.4 ± 5.0*117.7 ± 4.4*78.9 ± 1.5*
Norepinephrine0.274.9 ± 1.8*89.0 ± 1.2*67.7 ± 2.9*65.3 ± 3.8*
PAH0.296.6 ± 6.0132.0 ± 3.6*105.3 ± 2.0102.6 ± 4.1
Procainamide0.296.4 ± 3.058.2 ± 1.0*93.3 ± 3.330.5 ± 1.3*
Serotonin0.293.3 ± 2.944.9 ± 2.0*107.2 ± 4.469.2 ± 4.0*
TEA254.6 ± 2.7*23.6 ± 0.2*88.4 ± 1.9*27.0 ± 0.2*
TPP0.212.9 ± 1.6*13.0 ± 0.5*67.9 ± 3.3*26.4 ± 0.3*
Verapamil0.2N.D.10.8 ± 0.6*10.9 ± 1.4*11.8 ± 0.7*
  • MPP, 1-methyl-4-phenylpyridinium; NMN, N-methylnicotinamide; PAH, p-aminohippurate; TPP, thiamine pyrophosphate; N.D., not detected.

  • * Significantly different from the value for control at p < 0.05.